This outcome is not surprising outcome insofar as the phase-2 trial of VIR-2484, the lead compound of the collaboration, was a failure ( #msg-172395320).
“The efficient-market hypothesis may be the foremost piece of B.S. ever promulgated in any area of human knowledge!”